EYPT short interest
EyePoint Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 20,788,240 |
|---|---|
| Change vs prior report | 978,679 (+4.9%) |
| Change over six months | +55.3% |
| Days to cover | 5.38 (sector: 3.78) |
| Average daily volume | 3,863,442 |
| Rank in Healthcare | #382 of 922 by days to cover |
EYPT short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 20,788,240 | +4.9% | 5.38 | 3,863,442 |
| 2026-09-15 | 19,809,561 | +9.4% | 6.43 | 3,079,759 |
| 2026-08-31 | 18,110,761 | -1.7% | 1.72 | 10,506,239 |
| 2026-08-14 | 18,426,891 | +2.3% | 9.10 | 2,024,578 |
| 2026-07-31 | 18,015,023 | +9.7% | 12.35 | 1,458,571 |
| 2026-07-15 | 16,425,378 | +8.7% | 10.33 | 1,590,009 |
| 2026-06-30 | 15,114,767 | +0.2% | 9.61 | 1,572,696 |
| 2026-06-15 | 15,077,303 | -0.1% | 13.84 | 1,089,633 |
| 2026-05-29 | 15,097,978 | +6.7% | 15.09 | 1,000,348 |
| 2026-05-15 | 14,152,914 | -0.2% | 16.88 | 838,595 |
| 2026-04-30 | 14,186,473 | +3.9% | 16.59 | 855,027 |
| 2026-04-15 | 13,659,042 | +2.0% | 15.93 | 857,198 |
| 2026-03-31 | 13,385,952 | +7.3% | 14.06 | 951,760 |
| 2026-03-13 | 12,478,689 | +14.8% | 7.52 | 1,660,054 |
| 2026-02-27 | 10,868,767 | +14.1% | 4.51 | 2,410,231 |
| 2026-02-13 | 9,529,005 | +10.3% | 7.86 | 1,212,516 |
| 2026-01-30 | 8,638,845 | +4.4% | 9.51 | 908,851 |
| 2026-01-15 | 8,272,026 | -4.2% | 8.54 | 969,032 |
| 2025-12-31 | 8,632,273 | +18.1% | 6.61 | 1,305,856 |
| 2025-12-15 | 7,308,090 | -7.3% | 6.63 | 1,101,735 |
| 2025-11-28 | 7,881,028 | -8.7% | 7.08 | 1,112,401 |
| 2025-11-14 | 8,632,226 | +14.2% | 5.88 | 1,468,435 |
| 2025-10-31 | 7,558,136 | -7.0% | 5.85 | 1,292,705 |
| 2025-10-15 | 8,125,396 | +1.5% | 5.42 | 1,498,424 |
| 2025-09-30 | 8,002,454 | -10.0% | 7.33 | 1,091,310 |
import finzdata as yf
yf.Ticker("EYPT").short_interest # every report since 2017
yf.Client().short_interest(["EYPT"], start="2018-01-01")Healthcare short interest · EYPT price history · Who owns EYPT · All short interest